BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:W. Europe Standard Time
BEGIN:STANDARD
DTSTART:20251002T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=3;BYMINUTE=0;BYMONTH=10
TZNAME:W. Europe Standard Time
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:W. Europe Daylight Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:MASLP Prem Ranjan\, Senior Product Manager\, Electric Acoustic 
 Stimulation&nbsp\;&nbsp\;&nbsp\;&nbsp\;In this webinar\, the latest FDA ap
 proval of a hearing preservation claim will be discussed. We will also dis
 cuss how this will influence candidates with residual hearing who decide t
 o go for EAS or CI. Literature\, counseling\, and outcomes will also be di
 scussed.
DTEND:20250515T124500Z
DTSTAMP:20260512T062427Z
DTSTART:20250515T120000Z
LOCATION:
SEQUENCE:0
SUMMARY:Hearing Preservation and EAS
UID:RFCALITEM639141638679577120
X-ALT-DESC;FMTTYPE=text/html:<div class="col-md-12 col-sm-12" style="paddin
 g:0\;"><div class="col-xs-12 col-sm-4 col-md-4 col-lg-4" style="padding:0\
 ;"><img sf-image-responsive="true" src="https://sfc01.cdn.medel.com/images
 /librariesprovider2/events/eventsonline/speaker-images/prem-ranjan.png?aut
 o=format&amp\;sfvrsn=befabd43_0&amp\;sf_site_temp=true&amp\;sf_site=1babf3
 8b-2f17-64e6-80bd-ff09000c6e28" height="157" style="max-width:100%\;height
 :auto\;" title="Prem Ranjan" width="157" alt="Prem Ranjan" sf-size="28856"
  /><div>MASLP Prem Ranjan\, Senior Product Manager\, Electric Acoustic Sti
 mulation</div></div><div class="col-xs-12 col-sm-4 col-md-4 col-lg-4 hidde
 n-xs" style="padding:0\;"><div>&nbsp\;</div><div>&nbsp\;</div></div><div c
 lass="col-xs-12 col-sm-4 col-md-4 col-lg-4 hidden-xs" style="padding:0\;">
 <div>&nbsp\;</div><div>&nbsp\;</div></div></div><div class="col-lg-12 col-
 md-12 col-sm-12 col-xs-12 margin-bottom-2x margin-top-2x" style="padding:0
 \;">In this webinar\, the latest FDA approval of a hearing preservation cl
 aim will be discussed. We will also discuss how this will influence candid
 ates with residual hearing who decide to go for EAS or CI. Literature\, co
 unseling\, and outcomes will also be discussed.</div>
END:VEVENT
END:VCALENDAR